Last Updated on September 10, 2024 by The Health Master
Pakistan
A recent meeting of the Senate Standing Committee on National Health Services in Islamabad highlighted serious concerns regarding the quality of drug production in Pakistan.
The committee expressed disappointment that many locally produced drugs fail to meet international standards, raising questions about the effectiveness and safety of medications available to Pakistani citizens.
DRAP’s Performance Under Review
The Senate committee focused on the Drug Regulatory Authority of Pakistan (DRAP), the government agency responsible for overseeing the pharmaceutical industry.
Officials from DRAP presented a review of their performance over the past five years, outlining their role in licensing, manufacturing, and quality control of drugs.
Quality Concerns and International Standards
Senators expressed deep concern about the quality of drugs manufactured in Pakistan.
They noted that many products do not meet international standards, potentially endangering the health of consumers.
The committee questioned the presence of multinational pharmaceutical companies in Pakistan and the rumors of their departure.
Formula Milk Regulation and Controversy
The committee also discussed the issue of formula milk regulation.
DRAP’s CEO, Asim Rauf, explained that formula milk companies had previously challenged DRAP’s authority to regulate the product, but the court ruled in favor of the regulatory body.
NRE Passing Criteria and Concerns
The Senate body addressed the new policy for the National Registration Examination (NRE), a crucial exam for foreign medical students seeking to practice in Pakistan.
The PMDC President, Rizwan Taj, revealed that the passing criteria had been lowered from 70% to 60%, leading to a significant increase in the NRE passing rate.
This change raised concerns about the quality of medical education and the competence of foreign medical graduates.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Pakistan: Pharma Company Faces Imprisonment and Fines for NSQ Drug
Pakistan in Healthcare Crisis: Struggle to Afford Life-Saving Medicines
Key Notes on Revised Schedule M: Must read
Important short notes for Industry and Regulators
CDSCO Guidelines on Drug Recall
Quality Assurance Vs Quality Control in the Pharma Industry
Major FDA audit findings about Equipment and Instruments
Understanding GMP, cGMP, and WHO-GMP
Quality Assurance in the Pharmaceutical Industry
Duties and responsibilities of QA person in Pharma Industry
Difference: Disintegration and Dissolution test in pharma industry
Understanding DQ, IQ, PQ, and OQ in the Pharma Industry
NDPS: Illegal Drug Manufacturing Unit busted in East Godavari
USFDA issues EIR for Marksans Pharma Goa facility
Indian Pharma Industry: A Global Powerhouse
USFDA approval granted for generic drug for Scalp Psoriasis Treatment
Huge stock of medicines seized: DCA Telangana
FSSAI: Food Labelling and Display – Chapter-9
USFDA issues warning letter to Zydus for injectables unit at Jarod
Streamlining Indian Pharmaceutical Regulatory System: DCGI
Strengthening Drug Regulatory System in India: A Comprehensive Analysis
USFDA approval granted for Brimonidine Tartrate Ophthalmic Solution: Lupin
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
